Lineage Cell Therapeutics Inc. (BT3)
Market Closed
17 Jul, 20:00
XFRA 
€
0. 98
-0.05
-5.0193%
€
- Market Cap
- P/E Ratio
- Div Yield
3,000 Volume
-0.11 Eps
€ 1.04
Previous Close Want to track BT3 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
BT3 Earnings Reports FAQ
What is the earnings per share (EPS) for BT3?
The current EPS is -0.11.
What is the company's earnings growth rate?
Lineage Cell Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Lineage Cell Therapeutics Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Lineage Cell Therapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for BT3 at this time, as Lineage Cell Therapeutics Inc has no recent EPS data to calculate it.
